• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:双重 SARS-CoV-2 感染期间优势株的变化。

Case report: change of dominant strain during dual SARS-CoV-2 infection.

机构信息

Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 111123, Moscow, Russia.

出版信息

BMC Infect Dis. 2021 Sep 16;21(1):959. doi: 10.1186/s12879-021-06664-w.

DOI:10.1186/s12879-021-06664-w
PMID:34530778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8443909/
Abstract

BACKGROUND

The dual infection with SARS-CoV-2 is poorly described and is currently under discussion. We present a study of two strains of SARS-CoV-2 detected in the same patient during the same disease presentation.

CASE PRESENTATION

A patient in their 90 s was hospitalised with fever. Oropharyngeal swab obtained on the next day (sample 1) tested positive for SARS-CoV-2. Five days later, the patient was transferred to the ICU (intensive care unit) of the hospital specialising in the treatment of COVID-19 patients, where the patient's condition progressively worsened and continuous oxygen insufflation was required. Repeated oropharyngeal swab (sample 2), which was taken eight days after the first one, also tested positive for SARS-CoV-2. After 5 days of ICU treatment, the patient died. The cause of death was a coronavirus infection, which progressed unfavourably due to premorbid status. We have performed sequencing of full SARS-CoV-2 genomes from oropharyngeal swabs obtained eight days apart. Genomic analysis revealed the presence of two genetically distant SARS-CoV-2 strains in both swabs. Detected strains belong to different phylogenetic clades (GH and GR) and differ in seven nucleotide positions. The relative abundance of strains was 70% (GH) and 30% (GR) in the first swab, and 3% (GH) and 97% (GR) in the second swab.

CONCLUSIONS

Our findings suggest that the patient was infected by two genetically distinct SARS-CoV-2 strains at the same time. One of the possible explanations is that the second infection was hospital-acquired. Change of the dominant strain ratio during disease manifestation could be explained by the advantage or higher virulence of the GR clade strain.

摘要

背景

SARS-CoV-2 的双重感染描述甚少,目前仍存在争议。我们报告了一例在同一患者的同一疾病发作期间同时检测到两种 SARS-CoV-2 毒株的病例。

病例介绍

一位 90 多岁的患者因发热住院。次日获得的咽拭子标本(样本 1)检测出 SARS-CoV-2 阳性。5 天后,患者转至专门治疗 COVID-19 患者的医院 ICU,患者病情逐渐恶化,需要持续吸氧。第一次咽拭子 8 天后再次进行咽拭子检测(样本 2),结果仍为 SARS-CoV-2 阳性。在 ICU 治疗 5 天后,患者死亡。死亡原因是冠状病毒感染,由于合并疾病状态,病情恶化。我们对相隔 8 天获得的咽拭子进行了全 SARS-CoV-2 基因组测序。基因组分析显示,两个咽拭子中均存在两种遗传上不同的 SARS-CoV-2 株。检测到的株属于不同的系统发育枝(GH 和 GR),在 7 个核苷酸位置存在差异。第一份咽拭子中两种株的相对丰度分别为 70%(GH)和 30%(GR),第二份咽拭子中分别为 3%(GH)和 97%(GR)。

结论

我们的研究结果表明,患者同时感染了两种遗传上不同的 SARS-CoV-2 株。一种可能的解释是第二次感染是医院获得性的。在疾病表现过程中优势株比例的变化可能是由于 GR 枝株的优势或更高的毒力所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc3a/8444617/e56ea94f0977/12879_2021_6664_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc3a/8444617/1c67579b7625/12879_2021_6664_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc3a/8444617/e56ea94f0977/12879_2021_6664_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc3a/8444617/1c67579b7625/12879_2021_6664_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc3a/8444617/e56ea94f0977/12879_2021_6664_Fig2_HTML.jpg

相似文献

1
Case report: change of dominant strain during dual SARS-CoV-2 infection.病例报告:双重 SARS-CoV-2 感染期间优势株的变化。
BMC Infect Dis. 2021 Sep 16;21(1):959. doi: 10.1186/s12879-021-06664-w.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Molecular Detection of SARS-CoV-2 From Throat Swabs Performed With or Without Specimen Collection From the Tonsils: Protocol for a Multicenter Randomized Controlled Trial.从扁桃体采集或不采集样本的咽喉拭子对 SARS-CoV-2 的分子检测:一项多中心随机对照试验方案。
JMIR Res Protoc. 2024 Jun 12;13:e47446. doi: 10.2196/47446.
4
Feasibility of using alternative swabs and storage solutions for paired SARS-CoV-2 detection and microbiome analysis in the hospital environment.在医院环境中,使用替代拭子和储存溶液进行配对 SARS-CoV-2 检测和微生物组分析的可行性。
Microbiome. 2021 Jan 22;9(1):25. doi: 10.1186/s40168-020-00960-4.
5
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病(NO COVID-19)实用开放性标签研究,评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
6
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
7
Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.对确诊和疑似 COVID-19 患者的鼻咽拭子标本进行宏基因组下一代测序。
mBio. 2020 Nov 20;11(6):e01969-20. doi: 10.1128/mBio.01969-20.
8
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.一项针对高风险确诊严重 SARS-CoV-2 疾病患者的随机开放标签 II 期临床试验,比较 SARS-CoV-2 感染后恢复期患者输注血浆与未输注血浆的疗效(RECOVER):一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Oct 6;21(1):828. doi: 10.1186/s13063-020-04735-y.
9
Myoclonus status revealing COVID 19 infection.肌阵挛状态揭示 COVID-19 感染。
Seizure. 2023 Jan;104:12-14. doi: 10.1016/j.seizure.2022.11.010. Epub 2022 Nov 22.
10
Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan.日本广岛市首次和第二次新冠病毒爆发期间的 SARS-CoV-2 的分子特征和突变模式。
PLoS One. 2021 Feb 5;16(2):e0246383. doi: 10.1371/journal.pone.0246383. eCollection 2021.

引用本文的文献

1
Temporal dynamics of SARS-CoV-2 shedding in feces and saliva: a longitudinal study in Norfolk, United Kingdom during the 2021-2022 COVID-19 waves.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在粪便和唾液中的排出时间动态:2021 - 2022年新冠疫情期间在英国诺福克郡的一项纵向研究。
Microbiol Spectr. 2025 Mar 25;13(5):e0319524. doi: 10.1128/spectrum.03195-24.
2
Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples.在超过 200 万个全球 SARS-CoV-2 样本中系统检测共感染和宿主内重组。
Nat Commun. 2024 Jan 15;15(1):517. doi: 10.1038/s41467-023-43391-z.
3
An open-source, automated, and cost-effective platform for COVID-19 diagnosis and rapid portable genomic surveillance using nanopore sequencing.

本文引用的文献

1
Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology.SARS-CoV-2 进化枝的全球动态及其与 COVID-19 流行病学的关系。
Sci Rep. 2021 Apr 19;11(1):8435. doi: 10.1038/s41598-021-87713-x.
2
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.SARS-CoV-2 刺突蛋白 D614G 突变增加了病毒粒子刺突密度和感染力。
Nat Commun. 2020 Nov 26;11(1):6013. doi: 10.1038/s41467-020-19808-4.
3
Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.
一种使用纳米孔测序进行 COVID-19 诊断和快速便携基因组监测的开源、自动化且具有成本效益的平台。
Sci Rep. 2023 Nov 21;13(1):20349. doi: 10.1038/s41598-023-47190-w.
4
The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2.刺突蛋白的氨基酸取代和基因组重组对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进化的影响。
Front Microbiol. 2023 Jul 25;14:1228128. doi: 10.3389/fmicb.2023.1228128. eCollection 2023.
5
Strain-stream model of epidemic spread in application to COVID-19.应用于新型冠状病毒肺炎的疫情传播应变-流模型
Eur Phys J B. 2022;95(11):194. doi: 10.1140/epjb/s10051-022-00457-z. Epub 2022 Nov 29.
6
Molecular characterization of a new SARS-CoV-2 recombinant cluster XAG identified in Brazil.在巴西发现的新型严重急性呼吸综合征冠状病毒2重组群XAG的分子特征
Front Med (Lausanne). 2022 Sep 28;9:1008600. doi: 10.3389/fmed.2022.1008600. eCollection 2022.
7
Global asymptotic stability, extinction and ergodic stationary distribution in a stochastic model for dual variants of SARS-CoV-2.SARS-CoV-2双变体随机模型中的全局渐近稳定性、灭绝和遍历平稳分布
Math Comput Simul. 2023 Feb;204:302-336. doi: 10.1016/j.matcom.2022.08.012. Epub 2022 Aug 29.
8
Genomic evidence for divergent co-infections of co-circulating SARS-CoV-2 lineages.共同传播的新冠病毒谱系发生不同共感染的基因组证据。
Comput Struct Biotechnol J. 2022;20:4015-4024. doi: 10.1016/j.csbj.2022.07.042. Epub 2022 Jul 28.
9
Infection with SARS-CoV-2 Omicron Variant 24 Days after Non-Omicron Infection, Pennsylvania, USA.美国宾夕法尼亚州,非奥密克戎感染 24 天后感染 SARS-CoV-2 奥密克戎变异株 2 型。
Emerg Infect Dis. 2022 Sep;28(9):1911-1913. doi: 10.3201/eid2809.220539. Epub 2022 Aug 1.
10
Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing.通过前瞻性筛查和测序发现德尔塔和奥密克戎 SARS-CoV-2 变异株共同流行期间存在合并感染的证据。
Clin Microbiol Infect. 2022 Nov;28(11):1503.e5-1503.e8. doi: 10.1016/j.cmi.2022.06.030. Epub 2022 Jul 2.
SARS-CoV-2 的保守基因组末端作为共进化的功能元件和潜在的治疗靶点。
mSphere. 2020 Nov 25;5(6):e00754-20. doi: 10.1128/mSphere.00754-20.
4
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.严重急性呼吸综合征冠状病毒2型在免疫功能低下宿主中的持续存在与演变
N Engl J Med. 2020 Dec 3;383(23):2291-2293. doi: 10.1056/NEJMc2031364. Epub 2020 Nov 11.
5
The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals.HIV与SARS-CoV-2合并感染的前6个月:6947例个体的结局
Curr Opin HIV AIDS. 2021 Jan;16(1):54-62. doi: 10.1097/COH.0000000000000654.
6
SARS-CoV-2-related pneumonia cases in pneumonia picture in Russia in March-May 2020: Secondary bacterial pneumonia and viral co-infections.2020 年 3 月至 5 月俄罗斯肺炎图像中的 SARS-CoV-2 相关肺炎病例:继发性细菌性肺炎和病毒合并感染。
J Glob Health. 2020 Dec;10(2):020504. doi: 10.7189/jogh.10.020504.
7
Spike mutation D614G alters SARS-CoV-2 fitness.刺突突变 D614G 改变了 SARS-CoV-2 的适应性。
Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26.
8
Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的基因谱及独特进化模式
Front Microbiol. 2020 Sep 25;11:593548. doi: 10.3389/fmicb.2020.593548. eCollection 2020.
9
Genomic evidence for reinfection with SARS-CoV-2: a case study.基因组证据表明 SARS-CoV-2 再次感染:一项案例研究。
Lancet Infect Dis. 2021 Jan;21(1):52-58. doi: 10.1016/S1473-3099(20)30764-7. Epub 2020 Oct 12.
10
Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants.SARS-CoV-2 的非同义突变导致表位丢失,并使其变体分离。
Microbes Infect. 2020 Nov-Dec;22(10):598-607. doi: 10.1016/j.micinf.2020.10.004. Epub 2020 Oct 10.